White House Presses Congress to Call Off Federal Hemp Ban

The Trump administration is making its most concrete push yet to stop a sweeping federal hemp ban set to take effect this fall, asking Congress to either replace the law with a new regulatory framework or, failing that, delay it. To force the issue, the White House has bundled the request into an $87.6 billion war-funding package that otherwise has nothing to do with cannabis.

In a June 24, 2026 letter to House Speaker Mike Johnson (R-LA), White House budget director Russell Vought asked lawmakers to revise federal hemp rules to ensure the “fair treatment of hemp products.” He pointed to a regulatory framework from Rep. Andy Barr (R-KY) as the administration’s preferred fix, or, if that fails, at least an extension of the deadline now bearing down on the industry.

What the deadline does

The hemp provision Congress passed last year, signed in November 2025, narrows the federal definition of hemp to a total-THC standard and caps finished products at 0.4 milligrams of total THC per container. The change takes effect November 12, 2026. Products that exceed that limit stop counting as legal hemp and revert to marijuana — a Schedule I controlled substance under federal law.

The reach is broad. The U.S. Hemp Roundtable, an industry trade group, estimates the redefinition would eliminate the large majority of hemp-derived products now on the market — not only intoxicating delta-8 and THC items, but also the full-spectrum CBD that many consumers use for pain and sleep. Hemp farmers who shifted from commodity crops to cannabinoid varieties face a sharper version of the same problem: a harvest that could be federally controlled before it ever reaches a shelf. The Food and Drug Administration, for its part, has missed deadlines to publish the cannabinoid lists and container definitions the law requires, leaving the industry planning against a rule that still isn’t fully written.

What the Barr framework would do

The administration’s request would update the federal definition of finished hemp products to keep full-spectrum CBD available while restricting items that, in the letter’s words, “pose serious health risks.” That tracks the approach Barr has championed.

Rather than banning the category, Barr’s plan would keep many hemp products legal under a federal rulebook: a 21-and-older purchase age, mandatory labeling and government warnings, FDA limits on how much of each cannabinoid a product may contain, a federal excise tax and a retail user fee collected through the Treasury’s alcohol bureau, and an alcohol-style three-tier distribution system for hemp beverages.

It would also leave states in charge of their own markets. The framework preserves state authority to impose stricter limits, or even outright bans, within their borders, while preventing states from blocking shipments of products that meet the federal standard. That distinction matters because the states are already split. Colorado, Virginia, New Jersey and others have adopted total-THC caps that resemble the coming federal rule, while states that police only delta-9 THC would see far more of their shelves affected once the cutoff hits.

A difficult path through Congress

The letter caps a string of administration signals. The posture builds on a December 2025 executive order in which Trump called for expanded research into hemp-derived CBD; he publicly urged Congress in April 2026 to protect full-spectrum CBD products; and the White House used nearly identical language in a formal statement on the House agriculture spending bill earlier in June. After the House Rules Committee blocked Barr’s amendment from reaching a floor vote, the administration rerouted the request through the supplemental.

That vehicle is awkward. The $87.6 billion package is meant mostly to replenish the Pentagon after the U.S. operation against Iran, with additional money for farmers and for the Ebola outbreak in Central Africa — and Democrats have already objected to the war spending. Vought urged Congress to act quickly, but it is far from clear that the hemp language survives, or that lawmakers take up the package at all.

Barr is separately preparing a standalone bill, which he has said draws resistance from an unusual coalition of alcohol interests, marijuana businesses, and anti-legalization groups. The administration, meanwhile, has expanded hemp access on other fronts, including a Medicare program that now covers some hemp-derived CBD products for eligible patients.

For operators and retailers, the practical issue is timing. With the November cutoff closing in and no fix yet moving through Congress, businesses have to plan for three outcomes at once: a replacement framework, a delay, or a ban that lands exactly as written.